PAA 6.67% 21.0¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1208

  1. 2,235 Posts.
    lightbulb Created with Sketch. 2742
    Thought this was interesting.

    An article on the ALS Association website from Feb, 2024.

    Subsiding/grants to help 6 companies with pre-clinical drug development to fast track most promising areas for ALS.

    Have a look at the first two - promoting Autophagy!

    We are clearly in an area already heavily targetted as having huge potential.
    This little Aussie biotech coming out of nowhere with highly successful phase 1 clinical trial results under it's belt , preparing for phase 2/3, must be causing quite a stir.

    https://hotcopper.com.au/data/attachments/6134/6134285-4228cb73256fdd07f2471c239e21bd75.jpg
    https://hotcopper.com.au/data/attachments/6134/6134286-61b862b934443d0e94bdc3912618f57d.jpg
    https://hotcopper.com.au/data/attachments/6134/6134287-ccc9f368862c5e610a1dfef745c09e8f.jpg
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.015(6.67%)
Mkt cap ! $83.14M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $285.0K 1.389M

Buyers (Bids)

No. Vol. Price($)
3 398000 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 107156 5
View Market Depth
Last trade - 14.08pm 21/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.